The Uganda Peoples’ Defence Forces (UPDF), through its Health Services, has rolled out lenacapavir, a long-acting injectable Pre-Exposure Prophylaxis (PrEP) drug for HIV prevention which is administered once every six months, in a move aimed at strengthening its HIV response efforts.Spea
Global health is evolving rapidly, with breakthroughs turning into medicine.The latest advancement in viral research is Lenacapavir, an FDA-approved HIV injectable drug manufactured by American biopharmaceutical company Gilead Sciences.Renowned as a convenient, long-acting alternati
Uganda has received its first 19,200 doses of Lenacapavir, a twice-yearly injectable HIV prevention drug supported by the Global Fund and PEPFAR, targeting high-burden districts to curb new infections.Lenacapavir, a twice-yearly HIV prevention injection, is now accessible in Uganda.
Kampala — Uganda has approved Lenacapavir, a twice-yearly injectable HIV prevention medicine developed by Gilead Sciences, in a move health officials say could accelerate the country’s drive to sharply cut new infections and meet global targets to end AIDS as a public health threat by the end
Twenty-five years ago, South Africans battled for ARVs to keep people alive. Now the focus has shifted to medicines that can prevent HIV altogether. Health Beat looks how the story has evolvedSouth Africa has successfully registered twice-a-year anti-HIV jab, lenacapavir.This World
Malawi yesterday launched Lenacapavir, a twice-yearly injectable HIV prevention medicine amid reflections on whether the country can sustainably finance emerging technologies in the face of waning donor support.Pharmacy and Medicines Regulatory Authority (PMRA) and National Aids Commission
You can now be vaccinated against HIV – but that does not mean you can be reckless, warns the Department of Healthscientist-hiv-vaccinationA scientist holds a batch of tests. Image: CDC on UnsplashFrom March 2026, people at high risk of contracting HIV will be able to visit
THE Medicines Control Authority of Zimbabwe (MCAZ) has approved a new long-acting medicine, Lenacapavir, to help prevent HIV infection.Lenacapavir, is used for pre-exposure prophylaxis (PrEP) in adults and adolescents who weigh at least 35kg.It is for people who are HIV-negative but
Minister of Health, Dr Jane Ruth Aceng, has welcomed a landmark global deal that will dramatically slash the cost of the HIV prevention drug, lenacapavir, making it affordable for millions in low- and middle-income countries.The announcement was made on W
USAID road localisation show. USAID had embarked on funding locally lead initiatives across Uganda. PHOTO URNKampala, Uganda | USAID has been present in Uganda for over sixty years. It has funded development in agriculture, education
